Legal Opinion
BIOVAIL LABORATORIES, INC. v. Torpharm, Inc.
District Court, E.D. Pennsylvania
Decided July 13, 2004No. 02-7119Published
1Opinion of the Court
MEMORANDUM AND ORDER
ANITA B. BRODY, District Judge.
INTRODUCTION
On September 3, 2002, plaintiff Biovail Laboratories, Inc. [“Biovail”] filed a complaint for patent infringement against defendant Torpharm, Inc. [“Torpharm”]. In its complaint, Biovail alleged that Torp-harm infringed two of its patents: U.S. Patent No. 5,529,791 [hereinafter “the ’791 patent”] and U.S. Patent No. 5,288,505 [hereinafter “the ’505 patent”] when Torp-harm filed an Abbreviated New Drug Application (“ANDA”) 1 for Diltiazem HC1 Capsules Type TZ (Diltiazem Hydrochloride Extended-Release Capsules USP) 120mg, 180mg,…
2Cases cited13 opinions
- MARKMAN Et Al. v. WESTVIEW INSTRUMENTS, INC., Et Al.Supreme Court of the United States · 1996
- Herbert Markman and Positek, Inc. v. Westview Instruments, Inc. And Althon Enterprises, Inc.Court of Appeals for the Federal Circuit · 1995
- Vitronics Corporation v. Conceptronic, Inc.Court of Appeals for the Federal Circuit · 1996
- Teleflex, Inc. v. Ficosa North America Corp., Fico Cables, S.A., and Ficosa North America S.A. De C.V.Court of Appeals for the Federal Circuit · 2002
- Ccs Fitness, Inc. v. Brunswick Corporation and Its Division Life FitnessCourt of Appeals for the Federal Circuit · 2002
8 more not listed; retrieve them via the Exa API.